Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 104 entries
Sorted by: Best Match Show Resources per page
Implicit and Explicit Communal Coping in Couples with Recently Diagnosed Type 2 Diabetes.

Journal of social and personal relationships

Helgeson VS, Jakubiak B, Seltman H, Hausmann L, Korytkowski M.
PMID: 29225393
J Soc Pers Relat. 2017;34(7):1099-1121. doi: 10.1177/0265407516669604. Epub 2016 Sep 22.

When an individual in a close relationship is diagnosed with a chronic illness, coping can be the responsibility of the patient, or couple-members can cope communally. Communal coping reflects a shared appraisal of a stressor (our problem instead of...

Cite
Helgeson VS, Jakubiak B, Seltman H, et al. Implicit and Explicit Communal Coping in Couples with Recently Diagnosed Type 2 Diabetes. J Soc Pers Relat. 2016;34(7):1099-1121doi: 10.1177/0265407516669604.
Helgeson, V. S., Jakubiak, B., Seltman, H., Hausmann, L., & Korytkowski, M. (2017). Implicit and Explicit Communal Coping in Couples with Recently Diagnosed Type 2 Diabetes. Journal of social and personal relationships, 34(7), 1099-1121. https://doi.org/10.1177/0265407516669604
Helgeson, Vicki S, et al. "Implicit and Explicit Communal Coping in Couples with Recently Diagnosed Type 2 Diabetes." Journal of social and personal relationships vol. 34,7 (2017): 1099-1121. doi: https://doi.org/10.1177/0265407516669604
Helgeson VS, Jakubiak B, Seltman H, Hausmann L, Korytkowski M. Implicit and Explicit Communal Coping in Couples with Recently Diagnosed Type 2 Diabetes. J Soc Pers Relat. 2017;34(7):1099-1121. doi: 10.1177/0265407516669604. Epub 2016 Sep 22. PMID: 29225393; PMCID: PMC5720377.
Copy Download .nbib Format: NLM
Strain-specific metabolic responses to long-term caloric restriction in female ILSXISS recombinant inbred mice.

Molecular and cellular endocrinology

Mulvey L, Wilkie SE, Borland G, Griffiths K, Sinclair A, McGuinness D, Watson DG, Selman C.
PMID: 34246728
Mol Cell Endocrinol. 2021 Sep 15;535:111376. doi: 10.1016/j.mce.2021.111376. Epub 2021 Jul 09.

The role that genetic background may play in the responsiveness of organisms to interventions such as caloric restriction (CR) is underappreciated but potentially important. We investigated the impact of genetic background on a suite of metabolic parameters in female...

Cite
Mulvey L, Wilkie SE, Borland G, et al. Strain-specific metabolic responses to long-term caloric restriction in female ILSXISS recombinant inbred mice. Mol Cell Endocrinol. 2021;535:111376doi: 10.1016/j.mce.2021.111376.
Mulvey, L., Wilkie, S. E., Borland, G., Griffiths, K., Sinclair, A., McGuinness, D., Watson, D. G., & Selman, C. (2021). Strain-specific metabolic responses to long-term caloric restriction in female ILSXISS recombinant inbred mice. Molecular and cellular endocrinology, 535111376. https://doi.org/10.1016/j.mce.2021.111376
Mulvey, Lorna, et al. "Strain-specific metabolic responses to long-term caloric restriction in female ILSXISS recombinant inbred mice." Molecular and cellular endocrinology vol. 535 (2021): 111376. doi: https://doi.org/10.1016/j.mce.2021.111376
Mulvey L, Wilkie SE, Borland G, Griffiths K, Sinclair A, McGuinness D, Watson DG, Selman C. Strain-specific metabolic responses to long-term caloric restriction in female ILSXISS recombinant inbred mice. Mol Cell Endocrinol. 2021 Sep 15;535:111376. doi: 10.1016/j.mce.2021.111376. Epub 2021 Jul 09. PMID: 34246728; PMCID: PMC8417819.
Copy Download .nbib Format: NLM
New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples.

Journal of public health (Oxford, England)

Sarkis R, Lichaa A, Mjaess G, Saliba M, Selman C, Lecoq-Julien C, Grandjean D, Jabbour NM.
PMID: 34164680
J Public Health (Oxf). 2021 Jun 23; doi: 10.1093/pubmed/fdab215. Epub 2021 Jun 23.

BACKGROUND: Early screening for COVID-19 is needed to limit the spread of the virus. The aim of this study is to test if the sniffer dogs can be successfully trained to identify subjects with COVID-19 for 'proof of concept'...

Cite
Sarkis R, Lichaa A, Mjaess G, et al. New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples. J Public Health (Oxf). 2021;doi: 10.1093/pubmed/fdab215.
Sarkis, R., Lichaa, A., Mjaess, G., Saliba, M., Selman, C., Lecoq-Julien, C., Grandjean, D., & Jabbour, N. M. (2021). New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples. Journal of public health (Oxford, England), . https://doi.org/10.1093/pubmed/fdab215
Sarkis, Riad, et al. "New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples." Journal of public health (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/pubmed/fdab215
Sarkis R, Lichaa A, Mjaess G, Saliba M, Selman C, Lecoq-Julien C, Grandjean D, Jabbour NM. New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples. J Public Health (Oxf). 2021 Jun 23; doi: 10.1093/pubmed/fdab215. Epub 2021 Jun 23. PMID: 34164680.
Copy Download .nbib Format: NLM
Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction.

JAMA cardiology

Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik J.
PMID: 33950162
JAMA Cardiol. 2021 Aug 01;6(8):957-962. doi: 10.1001/jamacardio.2021.0939.

IMPORTANCE: Heart failure with recovered ejection fraction (HFrecEF) is a recently recognized phenotype of patients with a history of reduced left ventricular ejection fraction (LVEF) that has subsequently normalized. It is unknown whether such LVEF improvement is associated with...

Cite
Wohlfahrt P, Nativi-Nicolau J, Zhang M, et al. Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA Cardiol. 2021;6(8):957-962doi: 10.1001/jamacardio.2021.0939.
Wohlfahrt, P., Nativi-Nicolau, J., Zhang, M., Selzman, C. H., Greene, T., Conte, J., Biber, J. E., Hess, R., Mondesir, F. L., Wever-Pinzon, O., Drakos, S. G., Gilbert, E. M., Kemeyou, L., LaSalle, B., Steinberg, B. A., Shah, R. U., Fang, J. C., Spertus, J. A., & Stehlik, J. (2021). Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA cardiology, 6(8), 957-962. https://doi.org/10.1001/jamacardio.2021.0939
Wohlfahrt, Peter, et al. "Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction." JAMA cardiology vol. 6,8 (2021): 957-962. doi: https://doi.org/10.1001/jamacardio.2021.0939
Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik J. Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA Cardiol. 2021 Aug 01;6(8):957-962. doi: 10.1001/jamacardio.2021.0939. PMID: 33950162; PMCID: PMC8100912.
Copy Download .nbib Format: NLM
Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus.

Rheumatology (Oxford, England)

Li D, Yoshida K, Feldman CH, Speyer C, Barbhaiya M, Guan H, Solomon DH, Everett BM, Costenbader KH.
PMID: 31504932
Rheumatology (Oxford). 2020 Mar 01;59(3):697. doi: 10.1093/rheumatology/kez433.

No abstract available.

Cite
Li D, Yoshida K, Feldman CH, et al. Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus. Rheumatology (Oxford). 2020;59(3):697doi: 10.1093/rheumatology/kez433.
Li, D., Yoshida, K., Feldman, C. H., Speyer, C., Barbhaiya, M., Guan, H., Solomon, D. H., Everett, B. M., & Costenbader, K. H. (2020). Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus. Rheumatology (Oxford, England), 59(3), 697. https://doi.org/10.1093/rheumatology/kez433
Li, Daniel, et al. "Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus." Rheumatology (Oxford, England) vol. 59,3 (2020): 697. doi: https://doi.org/10.1093/rheumatology/kez433
Li D, Yoshida K, Feldman CH, Speyer C, Barbhaiya M, Guan H, Solomon DH, Everett BM, Costenbader KH. Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus. Rheumatology (Oxford). 2020 Mar 01;59(3):697. doi: 10.1093/rheumatology/kez433. PMID: 31504932; PMCID: PMC7825008.
Copy Download .nbib Format: NLM
Cardiothoracic Surgery Residency Training in Surgical Ablation for Atrial Fibrillation.

Journal of atrial fibrillation

DeBoard ZM, Varghese TK, Doty JR, Selzman CH.
PMID: 31687071
J Atr Fibrillation. 2019 Jun 30;12(1):2195. doi: 10.4022/jafib.2195. eCollection 2019 Jun.

BACKGROUND: As no standardized curriculum exists for training cardiothoracic surgery residents in surgical ablation for atrial fibrillation there is potential for variation in operative technique, patient selection, and overall application. Thus we sought to assess the exposure of current...

Cite
DeBoard ZM, Varghese TK, Doty JR, et al. Cardiothoracic Surgery Residency Training in Surgical Ablation for Atrial Fibrillation. J Atr Fibrillation. 2019;12(1):2195doi: 10.4022/jafib.2195.
DeBoard, Z. M., Varghese, T. K., Doty, J. R., & Selzman, C. H. (2019). Cardiothoracic Surgery Residency Training in Surgical Ablation for Atrial Fibrillation. Journal of atrial fibrillation, 12(1), 2195. https://doi.org/10.4022/jafib.2195
DeBoard, Zachary M, et al. "Cardiothoracic Surgery Residency Training in Surgical Ablation for Atrial Fibrillation." Journal of atrial fibrillation vol. 12,1 (2019): 2195. doi: https://doi.org/10.4022/jafib.2195
DeBoard ZM, Varghese TK, Doty JR, Selzman CH. Cardiothoracic Surgery Residency Training in Surgical Ablation for Atrial Fibrillation. J Atr Fibrillation. 2019 Jun 30;12(1):2195. doi: 10.4022/jafib.2195. eCollection 2019 Jun. PMID: 31687071; PMCID: PMC6811342.
Copy Download .nbib Format: NLM
Untangling the complexity of medication adherence in SLE.

Nature reviews. Rheumatology

Drenkard C, Feldman CH.
PMID: 32792662
Nat Rev Rheumatol. 2020 Nov;16(11):605-606. doi: 10.1038/s41584-020-0490-5.

No abstract available.

Cite
Drenkard C, Feldman CH. Untangling the complexity of medication adherence in SLE. Nat Rev Rheumatol. 2020;16(11):605-606doi: 10.1038/s41584-020-0490-5.
Drenkard, C., & Feldman, C. H. (2020). Untangling the complexity of medication adherence in SLE. Nature reviews. Rheumatology, 16(11), 605-606. https://doi.org/10.1038/s41584-020-0490-5
Drenkard, Cristina, and Feldman, Candace H. "Untangling the complexity of medication adherence in SLE." Nature reviews. Rheumatology vol. 16,11 (2020): 605-606. doi: https://doi.org/10.1038/s41584-020-0490-5
Drenkard C, Feldman CH. Untangling the complexity of medication adherence in SLE. Nat Rev Rheumatol. 2020 Nov;16(11):605-606. doi: 10.1038/s41584-020-0490-5. PMID: 32792662.
Copy Download .nbib Format: NLM
A possible billion-year-old holozoan with differentiated multicellularity.

Current biology : CB

Strother PK, Brasier MD, Wacey D, Timpe L, Saunders M, Wellman CH.
PMID: 33852871
Curr Biol. 2021 Jun 21;31(12):2658-2665.e2. doi: 10.1016/j.cub.2021.03.051. Epub 2021 Apr 13.

Sediments of the Torridonian sequence of the Northwest Scottish Highlands contain a wide array of microfossils, documenting life in a non-marine setting a billion years ago (1 Ga).

Cite
Strother PK, Brasier MD, Wacey D, et al. A possible billion-year-old holozoan with differentiated multicellularity. Curr Biol. 2021;31(12):2658-2665.e2doi: 10.1016/j.cub.2021.03.051.
Strother, P. K., Brasier, M. D., Wacey, D., Timpe, L., Saunders, M., & Wellman, C. H. (2021). A possible billion-year-old holozoan with differentiated multicellularity. Current biology : CB, 31(12), 2658-2665.e2. https://doi.org/10.1016/j.cub.2021.03.051
Strother, Paul K, et al. "A possible billion-year-old holozoan with differentiated multicellularity." Current biology : CB vol. 31,12 (2021): 2658-2665.e2. doi: https://doi.org/10.1016/j.cub.2021.03.051
Strother PK, Brasier MD, Wacey D, Timpe L, Saunders M, Wellman CH. A possible billion-year-old holozoan with differentiated multicellularity. Curr Biol. 2021 Jun 21;31(12):2658-2665.e2. doi: 10.1016/j.cub.2021.03.051. Epub 2021 Apr 13. PMID: 33852871.
Copy Download .nbib Format: NLM
What are the obligations of pharmaceutical companies in a global health emergency?.

Lancet (London, England)

Emanuel EJ, Buchanan A, Chan SY, Fabre C, Halliday D, Heath J, Herzog L, Leland RJ, McCoy MS, Norheim OF, Saenz C, Schaefer GO, Tan KC, Wellman CH, Wolff J, Persad G.
PMID: 34364412
Lancet. 2021 Sep 11;398(10304):1015-1020. doi: 10.1016/S0140-6736(21)01378-7. Epub 2021 Aug 06.

No abstract available.

Cite
Emanuel EJ, Buchanan A, Chan SY, et al. What are the obligations of pharmaceutical companies in a global health emergency?. Lancet. 2021;398(10304):1015-1020doi: 10.1016/S0140-6736(21)01378-7.
Emanuel, E. J., Buchanan, A., Chan, S. Y., Fabre, C., Halliday, D., Heath, J., Herzog, L., Leland, R. J., McCoy, M. S., Norheim, O. F., Saenz, C., Schaefer, G. O., Tan, K. C., Wellman, C. H., Wolff, J., & Persad, G. (2021). What are the obligations of pharmaceutical companies in a global health emergency?. Lancet (London, England), 398(10304), 1015-1020. https://doi.org/10.1016/S0140-6736(21)01378-7
Emanuel, Ezekiel J, et al. "What are the obligations of pharmaceutical companies in a global health emergency?." Lancet (London, England) vol. 398,10304 (2021): 1015-1020. doi: https://doi.org/10.1016/S0140-6736(21)01378-7
Emanuel EJ, Buchanan A, Chan SY, Fabre C, Halliday D, Heath J, Herzog L, Leland RJ, McCoy MS, Norheim OF, Saenz C, Schaefer GO, Tan KC, Wellman CH, Wolff J, Persad G. What are the obligations of pharmaceutical companies in a global health emergency?. Lancet. 2021 Sep 11;398(10304):1015-1020. doi: 10.1016/S0140-6736(21)01378-7. Epub 2021 Aug 06. PMID: 34364412; PMCID: PMC8342311.
Copy Download .nbib Format: NLM
RNA Polymerase III, Ageing and Longevity.

Frontiers in genetics

Kulaberoglu Y, Malik Y, Borland G, Selman C, Alic N, Tullet JMA.
PMID: 34295356
Front Genet. 2021 Jul 06;12:705122. doi: 10.3389/fgene.2021.705122. eCollection 2021.

Transcription in eukaryotic cells is performed by three RNA polymerases. RNA polymerase I synthesises most rRNAs, whilst RNA polymerase II transcribes all mRNAs and many non-coding RNAs. The largest of the three polymerases is RNA polymerase III (Pol III)...

Cite
Kulaberoglu Y, Malik Y, Borland G, et al. RNA Polymerase III, Ageing and Longevity. Front Genet. 2021;12:705122doi: 10.3389/fgene.2021.705122.
Kulaberoglu, Y., Malik, Y., Borland, G., Selman, C., Alic, N., & Tullet, J. M. A. (2021). RNA Polymerase III, Ageing and Longevity. Frontiers in genetics, 12705122. https://doi.org/10.3389/fgene.2021.705122
Kulaberoglu, Yavuz, et al. "RNA Polymerase III, Ageing and Longevity." Frontiers in genetics vol. 12 (2021): 705122. doi: https://doi.org/10.3389/fgene.2021.705122
Kulaberoglu Y, Malik Y, Borland G, Selman C, Alic N, Tullet JMA. RNA Polymerase III, Ageing and Longevity. Front Genet. 2021 Jul 06;12:705122. doi: 10.3389/fgene.2021.705122. eCollection 2021. PMID: 34295356; PMCID: PMC8290157.
Copy Download .nbib Format: NLM
Dan Sargent, CCO Associate Editor and Mayo biostatistician and clinical trialist, dies unexpectedly at 46.

Chinese clinical oncology

Seliman H.
PMID: 27829282
Chin Clin Oncol. 2016 Oct;5(5):69. doi: 10.21037/cco.2016.10.10.

No abstract available.

Cite
Seliman H. Dan Sargent, CCO Associate Editor and Mayo biostatistician and clinical trialist, dies unexpectedly at 46. Chin Clin Oncol. 2016;5(5):69doi: 10.21037/cco.2016.10.10.
Seliman, H. (2016). Dan Sargent, CCO Associate Editor and Mayo biostatistician and clinical trialist, dies unexpectedly at 46. Chinese clinical oncology, 5(5), 69. https://doi.org/10.21037/cco.2016.10.10
Seliman, Helen. "Dan Sargent, CCO Associate Editor and Mayo biostatistician and clinical trialist, dies unexpectedly at 46." Chinese clinical oncology vol. 5,5 (2016): 69. doi: https://doi.org/10.21037/cco.2016.10.10
Seliman H. Dan Sargent, CCO Associate Editor and Mayo biostatistician and clinical trialist, dies unexpectedly at 46. Chin Clin Oncol. 2016 Oct;5(5):69. doi: 10.21037/cco.2016.10.10. PMID: 27829282.
Copy Download .nbib Format: NLM
Hydrogen sulfide in ageing, longevity and disease.

The Biochemical journal

Wilkie SE, Borland G, Carter RN, Morton NM, Selman C.
PMID: 34613340
Biochem J. 2021 Oct 15;478(19):3485-3504. doi: 10.1042/BCJ20210517.

Hydrogen sulfide (H2S) modulates many biological processes, including ageing. Initially considered a hazardous toxic gas, it is now recognised that H2S is produced endogenously across taxa and is a key mediator of processes that promote longevity and improve late-life...

Cite
Wilkie SE, Borland G, Carter RN, et al. Hydrogen sulfide in ageing, longevity and disease. Biochem J. 2021;478(19):3485-3504doi: 10.1042/BCJ20210517.
Wilkie, S. E., Borland, G., Carter, R. N., Morton, N. M., & Selman, C. (2021). Hydrogen sulfide in ageing, longevity and disease. The Biochemical journal, 478(19), 3485-3504. https://doi.org/10.1042/BCJ20210517
Wilkie, Stephen E, et al. "Hydrogen sulfide in ageing, longevity and disease." The Biochemical journal vol. 478,19 (2021): 3485-3504. doi: https://doi.org/10.1042/BCJ20210517
Wilkie SE, Borland G, Carter RN, Morton NM, Selman C. Hydrogen sulfide in ageing, longevity and disease. Biochem J. 2021 Oct 15;478(19):3485-3504. doi: 10.1042/BCJ20210517. PMID: 34613340; PMCID: PMC8589328.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 104 entries